398 related articles for article (PubMed ID: 27307154)
41. Successful azathioprine treatment with metabolite monitoring in a pediatric inflammatory bowel disease patient homozygous for TPMT*3C.
Lee MN; Woo HI; Lee YM; Kang B; Kim JW; Choe YH; Lee SY
Yonsei Med J; 2013 Nov; 54(6):1545-9. PubMed ID: 24142665
[TBL] [Abstract][Full Text] [Related]
42. Deletion of glutathione-s-transferase m1 reduces azathioprine metabolite concentrations in young patients with inflammatory bowel disease.
Stocco G; Cuzzoni E; De Iudicibus S; Franca R; Favretto D; Malusà N; Londero M; Cont G; Bartoli F; Martelossi S; Ventura A; Decorti G
J Clin Gastroenterol; 2014 Jan; 48(1):43-51. PubMed ID: 23787247
[TBL] [Abstract][Full Text] [Related]
43. Development and validation of a rapid and reliable method for TPMT genotyping using real-time PCR.
Lorenz M; Weise A; Prause S; Klemm M; Eidens M; Luchi M; Forst T; Pfützner A; Weber MM
Clin Lab; 2012; 58(9-10):959-71. PubMed ID: 23163112
[TBL] [Abstract][Full Text] [Related]
44.
Moradveisi B; Muwakkit S; Zamani F; Ghaderi E; Mohammadi E; Zgheib NK
Front Pharmacol; 2019; 10():916. PubMed ID: 31507415
[No Abstract] [Full Text] [Related]
45. RT-PCR permits simultaneous genotyping of thiopurine S-methyltransferase allelic variants by multiplex induced heteroduplex analysis.
Wood N; Fraser A; Bidwell J; Standen G
Hum Mutat; 2004 Jul; 24(1):93-9. PubMed ID: 15221793
[TBL] [Abstract][Full Text] [Related]
46. Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.
Asadov C; Aliyeva G; Mustafayeva K
Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):23-30. PubMed ID: 28552060
[TBL] [Abstract][Full Text] [Related]
47. Thiopurine methyltransferase genotyping in Palestinian childhood acute lymphoblastic leukemia patients.
Ayesh BM; Harb WM; Abed AA
BMC Hematol; 2013 Apr; 13(1):3. PubMed ID: 24499706
[TBL] [Abstract][Full Text] [Related]
48. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine.
Evans WE; Hon YY; Bomgaars L; Coutre S; Holdsworth M; Janco R; Kalwinsky D; Keller F; Khatib Z; Margolin J; Murray J; Quinn J; Ravindranath Y; Ritchey K; Roberts W; Rogers ZR; Schiff D; Steuber C; Tucci F; Kornegay N; Krynetski EY; Relling MV
J Clin Oncol; 2001 Apr; 19(8):2293-301. PubMed ID: 11304783
[TBL] [Abstract][Full Text] [Related]
49. Combined evaluation of genotype and phenotype of thiopurine S-methyltransferase (TPMT) in the clinical management of patients in chronic therapy with azathioprine.
Rucci F; Cigoli MS; Marini V; Fucile C; Mattioli F; Robbiano L; Cavallari U; Scaglione F; Perno CF; Penco S; Marocchi A
Drug Metab Pers Ther; 2019 Mar; 34(1):. PubMed ID: 30840585
[TBL] [Abstract][Full Text] [Related]
50. The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia.
Wahlund M; Nilsson A; Kahlin AZ; Broliden K; Myrberg IH; Appell ML; Berggren A
J Pediatr; 2020 Jan; 216():150-157.e1. PubMed ID: 31635813
[TBL] [Abstract][Full Text] [Related]
51. Preparing Triple-Compound Heterozygous Control Material for Molecular Diagnostics of TPMT Allelic Variants.
Beránek M; Drastíková M; Bureš J; Palička V
Folia Biol (Praha); 2015; 61(3):91-6. PubMed ID: 26213853
[TBL] [Abstract][Full Text] [Related]
52. Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.
Di Salvo A; Fabiano C; Mannara V; Dimarco M; Orlando A; Affronti M; Macaluso FS; Cottone M
Dig Liver Dis; 2016 Dec; 48(12):1506-1509. PubMed ID: 27665263
[TBL] [Abstract][Full Text] [Related]
53. Beyond TPMT: genetic influences on thiopurine drug responses in inflammatory bowel disease.
Roberts RL; Gearry RB; Kennedy MA; Barclay ML
Per Med; 2008 May; 5(3):233-248. PubMed ID: 29783500
[TBL] [Abstract][Full Text] [Related]
54. Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn's disease patients.
Salazar J; Riera P; Gordillo J; Altès A; Martínez M; Serès M; Llaó J; Giordano A; Garcia-Planella E
Pharmacogenomics J; 2024 Jun; 24(4):20. PubMed ID: 38906864
[TBL] [Abstract][Full Text] [Related]
55. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).
Marinaki AM; Ansari A; Duley JA; Arenas M; Sumi S; Lewis CM; Shobowale-Bakre el-M; Escuredo E; Fairbanks LD; Sanderson JD
Pharmacogenetics; 2004 Mar; 14(3):181-7. PubMed ID: 15167706
[TBL] [Abstract][Full Text] [Related]
56. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
57. TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India.
Grover N; Bhatia P; Kumar A; Singh M; Lad D; Mandavdhare HS; Samanta J; Prasad KK; Dutta U; Sharma V
BMC Gastroenterol; 2021 Aug; 21(1):327. PubMed ID: 34425754
[TBL] [Abstract][Full Text] [Related]
58. Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine-related adverse drug reactions in the Chinese kidney transplant recipients.
Xiong H; Xin HW; Wu XC; Li Q; Xiong L; Yu AR
Fundam Clin Pharmacol; 2010 Jun; 24(3):393-400. PubMed ID: 19682085
[TBL] [Abstract][Full Text] [Related]
59. Genetic variations in the HGPRT, ITPA, IMPDH1, IMPDH2, and GMPS genes in Japanese individuals.
Kudo M; Saito Y; Sasaki T; Akasaki H; Yamaguchi Y; Uehara M; Fujikawa K; Ishikawa M; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2009; 24(6):557-64. PubMed ID: 20045992
[TBL] [Abstract][Full Text] [Related]
60. High-throughput genotyping of thiopurine S-methyltransferase by denaturing HPLC.
Schaeffeler E; Lang T; Zanger UM; Eichelbaum M; Schwab M
Clin Chem; 2001 Mar; 47(3):548-55. PubMed ID: 11238310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
